missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human IGBP1 (aa 13-127) Control Fragment Recombinant Protein
Click to view available options
Cantidad:
100 μL
Tamaño de la unidad:
100 microlitros
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (84%), Rat (84%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-51498 (PA5-51498. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The proliferation and differentiation of B cells is dependent upon a B-cell antigen receptor (BCR) complex. Binding of antigens to specific B-cell receptors results in a tyrosine phosphorylation reaction through the BCR complex and leads to multiple signal transduction pathways.
Especificaciones
Especificaciones
| Número de acceso | P78318 |
| Concentración | ≥5.0 mg/mL |
| Para utilizar con (aplicación) | Blocking Assay, Control |
| Formulación | 1 M urea, PBS with no preservative; pH 7.4 |
| ID de gen (Entrez) | 3476 |
| Nombre | Human IGBP1 (aa 13-127) Control Fragment |
| Cantidad | 100 μL |
| Estado normativo | RUO |
| Alias de gen | AI115586; AI662457; alpha 4; ALPHA-4; Alpha4 phosphoprotein; AW208785; B cell signal transduction molecule alpha 4; bA351K23.1 (immunoglobulin binding protein 1 (CD79A)); B-cell signal transduction molecule alpha 4; C81413; CD79a-binding protein 1; IBP1; Igbp1; immunoglobulin (CD79A) binding protein 1; immunoglobulin binding protein 1; immunoglobulin-binding protein 1; Lymphocyte signal transduction molecule alpha 4; p52; Pc52; phosphoprotein, component, 52 kDa; protein alpha-4; Protein phosphatase 2/4/6 regulatory subunit; protein phosphatase 2 A, regulatory subunit alpha-4; renal carcinoma antigen NY-REN-16; Tap42 |
| Nombre común | IGBP1 |
| Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido